U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 11.61% | 15.91% | 42.66% | -17.96% | -8.70% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.54% | -9.44% | -19.99% | 18.58% | -10.42% |
| Change in Net Operating Assets | 92.11% | 475.60% | -94.50% | 230.63% | 6.90% |
| Cash from Operations | 80.11% | 68.59% | 58.04% | 79.91% | -79.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 14.71% | -40.00% | 503.50% | -95.13% | -73.60% |
| Total Debt Repaid | 90.74% | 87.07% | 82.14% | -45.28% | -170.00% |
| Issuance of Common Stock | -100.00% | 0.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.03% | -14.13% | 1,013.79% | -94.77% | 286.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -374.73% | 118.40% | 98.66% | -105.85% | 114.51% |
